Skip to main content
Portfolio
TrendingElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive98AccountSocial
MARKETSINVESTLIVE98
Product
Kalshi ProInvestMarketsIncentive programSmall business hedgingInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQPrediction marketsFee scheduleTrading hoursRegulatoryTrust Center

© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
  1. Medicine

Will the FDA approve gedatolisib for advanced breast cancer?

4



Yes

Yes

Yes

Yes

Yes

Yes

2 more

Before Aug 1, 2026
100%
Before Oct 1, 2026
100%
Before Jan 1, 2027
100%
20%40%60%80%100%MayJunJul
$9,988 vol
More Science and Technology Markets

More Will the FDA approve drug? markets

Will the FDA approve cytisinicline for smoking cessation?Will the FDA approve CagriSema?Will the FDA approve intismeran autogene (V940/mRNA-4157)?Will the FDA approve MDMA for PTSD?

Trending Science and Technology markets

Best AI at the end of 2026?Will the U.S. confirm that aliens exist?OpenRouter token usage in Nov 16–22, 2026When will the Riemann Hypothesis be resolved?Anthropic market share this weekGoogle market share this weekWhere will Waymo operate this year?When will P vs NP be resolved?

Science and Technology hub

All Science and Technology markets
Illustration of gavel
Determined
Outcome: No
Explore Tech & Science